HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mamiko Yoshida Selected Research

Proteinuria

4/2011Recombinant human erythropoietin ameliorated endothelial dysfunction and macrophage infiltration by increasing nitric oxide in hypertensive 5/6 nephrectomized rat aorta.
4/2011L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mamiko Yoshida Research Topics

Disease

2Anemia
04/2011 - 06/2009
2Proteinuria
04/2011 - 04/2011
1Inflammation (Inflammations)
04/2011
1Hypertensive Nephropathy
04/2011
1Diabetic Nephropathies (Diabetic Nephropathy)
06/2009
1Reperfusion Injury
06/2009

Drug/Important Bio-Agent (IBA)

2ErythropoietinFDA Link
04/2011 - 06/2009
1Arginine (L-Arginine)FDA Link
04/2011
1CreatinineIBA
04/2011
1Desoxycorticosterone Acetate (DOCA)FDA Link
04/2011
1Acetates (Acetic Acid Esters)FDA Link
04/2011
1Desoxycorticosterone (Deoxycorticosterone)IBA
04/2011
1Amlodipine (Norvasc)FDA LinkGeneric
04/2011
1N-Type Calcium Channels (N-Type Calcium Channel)IBA
04/2011
1cilnidipineIBA
04/2011
1SaltsIBA
04/2011
1Streptozocin (Streptozotocin)FDA Link
06/2009